Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3.6000
+0.0400
+(1.12%)
As of 12:12:07 PM GMT+1. Market Open.
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
430.BE | -- | -- | -- | -- |
S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
Reiterates | JMP Securities: Market Outperform to Market Outperform | 12/4/2024 |
Reiterates | HC Wainwright & Co.: Neutral to Neutral | 12/4/2024 |
Maintains | Oppenheimer: Outperform to Outperform | 12/4/2024 |
Maintains | HC Wainwright & Co.: Neutral to Neutral | 11/13/2024 |
Initiated | Oppenheimer: Outperform | 10/31/2024 |
Reiterates | BMO Capital: Outperform to Outperform | 9/16/2024 |
Related Tickers
NICXF Nicox S.A.
0.2400
0.00%
ANL Adlai Nortye Ltd.
2.2203
+0.92%
TRDA Entrada Therapeutics, Inc.
12.02
-0.83%
CGEM Cullinan Therapeutics, Inc.
8.45
-1.29%
IMCR Immunocore Holdings plc
30.77
+5.34%
MNPR Monopar Therapeutics Inc.
31.29
+0.58%
AGIO Agios Pharmaceuticals, Inc.
34.44
-2.13%
PTGX Protagonist Therapeutics, Inc.
36.15
+3.02%
RNA Avidity Biosciences, Inc.
29.65
+1.68%
ADAP Adaptimmune Therapeutics plc
0.5870
+2.51%